{"id":12670,"date":"2023-05-30T11:31:13","date_gmt":"2023-05-30T11:31:13","guid":{"rendered":"https:\/\/dev.sunpharma.com\/?page_id=12670"},"modified":"2025-07-29T10:43:23","modified_gmt":"2025-07-29T05:13:23","slug":"isr","status":"publish","type":"page","link":"https:\/\/dev.sunpharma.com\/he\/isr\/","title":{"rendered":"ISR"},"content":{"rendered":"

[et_pb_section fb_built=”1″ fullwidth=”on” admin_label=”Popup – #undefined” _builder_version=”4.7.4″ background_image=”https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2023\/01\/iStock-1139040529-scaled.jpg” parallax=”on” animation_style=”fade” saved_tabs=”all” locked=”off” collapsed=”off” da_is_popup=”off” da_exit_intent=”off” da_has_close=”on” da_alt_close=”off” da_dark_close=”off” da_not_modal=”on” da_is_singular=”off” da_with_loader=”off” da_has_shadow=”on” da_disable_devices=”off|off|off”][et_pb_fullwidth_header title=”Investor Services” header_fullscreen=”on” button_one_url=”https:\/\/sun.stagingservice.net\/quality\/” button_two_url=”https:\/\/sun.stagingservice.net\/innovation\/” _builder_version=”4.7.4″ title_font=”|700|||||||” title_text_color=”#f7941e” title_font_size=”40px” title_line_height=”1.2em” content_font=”||||||||” content_text_color=”#000000″ content_font_size=”18px” content_line_height=”1.8em” subhead_font=”||||||||” subhead_text_color=”rgba(0,0,0,0.6)” subhead_font_size=”22px” background_color=”rgba(255,255,255,0.8)” custom_button_one=”on” button_one_text_size=”20px” button_one_text_color=”#ffffff” button_one_bg_color=”#f7941e” button_one_border_width=”0px” button_one_font=”|||on|||||” button_one_use_icon=”off” custom_button_two=”on” button_two_text_size=”20px” button_two_text_color=”rgba(0,0,0,0.7)” button_two_bg_color=”#ffffff” button_two_border_width=”0px” button_two_font=”|||on|||||” button_two_use_icon=”off” button_two_custom_margin=”||||false|false” button_two_custom_margin_tablet=”” button_two_custom_margin_phone=”|||1px|false|false” button_two_custom_margin_last_edited=”on|desktop” button_two_custom_padding=”||||false|false” background_layout=”light” width=”50%” width_tablet=”” width_phone=”100%” width_last_edited=”on|phone” animation_style=”fade” animation_duration=”500ms” animation_delay=”300ms” hover_enabled=”0″ title_font_tablet=”” title_font_phone=”” title_font_last_edited=”on|phone” content_font_tablet=”” content_font_phone=”” content_font_last_edited=”on|phone” sticky_enabled=”0″][\/et_pb_fullwidth_header][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.7.4″ _module_preset=”default” da_is_popup=”off” da_exit_intent=”off” da_has_close=”on” da_alt_close=”off” da_dark_close=”off” da_not_modal=”on” da_is_singular=”off” da_with_loader=”off” da_has_shadow=”on” da_disable_devices=”off|off|off”][et_pb_row _builder_version=”4.7.4″ _module_preset=”default” width=”80%”][et_pb_column type=”4_4″ _builder_version=”4.7.4″ _module_preset=”default”][et_pb_text _builder_version=”4.7.4″ _module_preset=”default”]<\/p>\n

Mandatory furnishing of PAN, KYC details and Nomination by holders of physical securities as per SEBI Circular.<\/strong><\/h2>\n

SEBI vide its circular no. SEBI\/HO\/MIRSD\/MIRSD-PoD-1\/P\/CIR\/2023\/37 dated March 16, 2023 (\u201cSEBI Circular\u201d) (Download SEBI Circular<\/a>) has mandated all the shareholders holding shares in physical form to update the PAN,\u00a0 KYC details, Nomination, Contact details, Bank A\/c details and Specimen signature for the respective folios. The abovementioned details can be updated by submitting the following forms, as may be applicable.<\/p>\n\n\n\n\n\n\n\n\n
\u00a0Request for Registering PAN, Mobile Number, E-mail address, other KYC details or changes \/ updation thereof<\/td>\nForm ISR-1<\/a><\/td>\n<\/tr>\n
Updation of signature of shareholder<\/td>\nForm ISR-2<\/a><\/td>\n<\/tr>\n
Declaration Form for Opting-out of Nomination by holders of physical securities<\/td>\nForm ISR-3<\/a><\/td>\n<\/tr>\n
Nomination Form<\/td>\nForm SH-13<\/a><\/td>\n<\/tr>\n
Cancellation or Variation of Nomination<\/td>\nForm SH-14<\/a><\/td>\n<\/tr>\n
The relevant form(s) along with the required documents shall be submitted with the Company\u2019s Registrar at the following address:<\/p>\n

Link Intime India Pvt. Ltd.<\/p>\n

C-101, 247 Park, L.B.S. Marg,<\/p>\n

Vikhroli (West), Mumbai \u2013 400083<\/p>\n

Maharashtra, India<\/p>\n

Tel. No. +91-22-49186000<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n

It is important to note that:<\/strong><\/p>\n

    \n
  1. RTAs (Registrar and Share Transfer Agents) shall not process any service request or complaint received from the security holder(s) \/ claimant(s), till PAN, contact details, Bank Account details, Specimen signature \u00a0and Nomination documents\/details are received.<\/li>\n
  2. The folios wherein any one of the documents \/ details cited in point 1 above are not available on or after October 01, 2023, shall be frozen by the RTA.<\/li>\n
  3. In case the folio(s) are frozen, then the shareholders would be able to avail any services, lodge any grievances or claim dividend etc. only upon furnishing necessary information and as per the terms and conditions specified in the SEBI Circular.\u00a0 The RTA shall revert the frozen folios to normal status upon receipt of all the documents\/details as mentioned above.<\/li>\n
  4. Effective from April 01, 2024 payment of dividend etc. shall be paid only through electronic mode.<\/li>\n
  5. Also, the Frozen folios shall be referred by the RTA \/ listed company to the administering authority under the Benami Transactions (Prohibitions) Act, 1988 and\/or Prevention of Money Laundering Act, 2002, if they continue to remain frozen as on December 31, 2025.<\/li>\n<\/ol>\n

    [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"

    Mandatory furnishing of PAN, KYC details and Nomination by holders of physical securities as per SEBI Circular. SEBI vide its circular no. SEBI\/HO\/MIRSD\/MIRSD-PoD-1\/P\/CIR\/2023\/37 dated March 16, 2023 (\u201cSEBI Circular\u201d) (Download SEBI Circular) has mandated all the shareholders holding shares in physical form to update the PAN,\u00a0 KYC details, Nomination, Contact details, Bank A\/c details and […]<\/p>\n","protected":false},"author":4,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"class_list":["post-12670","page","type-page","status-publish","hentry"],"yoast_head":"\nISR - Sun Pharmaceutical Industries Ltd.<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/dev.sunpharma.com\/he\/isr\/\" \/>\n<meta property=\"og:locale\" content=\"he_IL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ISR - Sun Pharmaceutical Industries Ltd.\" \/>\n<meta property=\"og:description\" content=\"Mandatory furnishing of PAN, KYC details and Nomination by holders of physical securities as per SEBI Circular. SEBI vide its circular no. SEBI\/HO\/MIRSD\/MIRSD-PoD-1\/P\/CIR\/2023\/37 dated March 16, 2023 (\u201cSEBI Circular\u201d) (Download SEBI Circular) has mandated all the shareholders holding shares in physical form to update the PAN,\u00a0 KYC details, Nomination, Contact details, Bank A\/c details and […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/dev.sunpharma.com\/he\/isr\/\" \/>\n<meta property=\"og:site_name\" content=\"Sun Pharmaceutical Industries Ltd.\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-29T05:13:23+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 \u05d3\u05e7\u05d5\u05ea\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/dev.sunpharma.com\\\/isr\\\/\",\"url\":\"https:\\\/\\\/dev.sunpharma.com\\\/isr\\\/\",\"name\":\"ISR - Sun Pharmaceutical Industries Ltd.\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dev.sunpharma.com\\\/#website\"},\"datePublished\":\"2023-05-30T11:31:13+00:00\",\"dateModified\":\"2025-07-29T05:13:23+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/dev.sunpharma.com\\\/isr\\\/#breadcrumb\"},\"inLanguage\":\"he-IL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/dev.sunpharma.com\\\/isr\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/dev.sunpharma.com\\\/isr\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/dev.sunpharma.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ISR\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/dev.sunpharma.com\\\/#website\",\"url\":\"https:\\\/\\\/dev.sunpharma.com\\\/\",\"name\":\"Sun Pharmaceutical Industries Ltd.\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/dev.sunpharma.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"he-IL\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ISR - Sun Pharmaceutical Industries Ltd.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/dev.sunpharma.com\/he\/isr\/","og_locale":"he_IL","og_type":"article","og_title":"ISR - Sun Pharmaceutical Industries Ltd.","og_description":"Mandatory furnishing of PAN, KYC details and Nomination by holders of physical securities as per SEBI Circular. SEBI vide its circular no. SEBI\/HO\/MIRSD\/MIRSD-PoD-1\/P\/CIR\/2023\/37 dated March 16, 2023 (\u201cSEBI Circular\u201d) (Download SEBI Circular) has mandated all the shareholders holding shares in physical form to update the PAN,\u00a0 KYC details, Nomination, Contact details, Bank A\/c details and […]","og_url":"https:\/\/dev.sunpharma.com\/he\/isr\/","og_site_name":"Sun Pharmaceutical Industries Ltd.","article_modified_time":"2025-07-29T05:13:23+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 \u05d3\u05e7\u05d5\u05ea"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/dev.sunpharma.com\/isr\/","url":"https:\/\/dev.sunpharma.com\/isr\/","name":"ISR - Sun Pharmaceutical Industries Ltd.","isPartOf":{"@id":"https:\/\/dev.sunpharma.com\/#website"},"datePublished":"2023-05-30T11:31:13+00:00","dateModified":"2025-07-29T05:13:23+00:00","breadcrumb":{"@id":"https:\/\/dev.sunpharma.com\/isr\/#breadcrumb"},"inLanguage":"he-IL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/dev.sunpharma.com\/isr\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/dev.sunpharma.com\/isr\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/dev.sunpharma.com\/"},{"@type":"ListItem","position":2,"name":"ISR"}]},{"@type":"WebSite","@id":"https:\/\/dev.sunpharma.com\/#website","url":"https:\/\/dev.sunpharma.com\/","name":"Sun Pharmaceutical Industries Ltd.","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dev.sunpharma.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"he-IL"}]}},"_links":{"self":[{"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/pages\/12670","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/comments?post=12670"}],"version-history":[{"count":13,"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/pages\/12670\/revisions"}],"predecessor-version":[{"id":13674,"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/pages\/12670\/revisions\/13674"}],"wp:attachment":[{"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/media?parent=12670"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}